Charité - Medical Department, Division of Gastroenterology, Infectiology and Rheumatology

The Central Biomaterial bank Charité (ZeBanC) supports projects of the Medical Clinic for Gastroenterology, Infectiology and Rheumatology such as the development of prognostic and predictive markers for gastric and esophageal adenocarcinomas by Dr. Christoph Treese. The EPO project is designed to generate patient-derived xenograft models for gastric and esophageal adenocarcinomas (EPO).
The ERGO study pursues the development of predictive biomarkers by sequential analysis under chemotherapy in gastric and esophageal adenocarcinomas (ERGO). The ZeBanC supports the biomaterial acquisition at the study centers and stores a portion of the materials for study purposes.


back

Contact

ZeBanC
t: +49 30 450 636 275 | 450 636 377
Logo_ISO9001_en